Ziprasidone Hydrochloride (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Ziprasidone Hydrochloride drug offered from Mylan Pharmaceuticals Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | ziprasidone hydrochloride |
SUBSTANCE NAME: | ZIPRASIDONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Atypical Antipsychotic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-06-24 |
END MARKETING DATE: | 2018-02-28 |
Ziprasidone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Ziprasidone Hydrochloride from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/1) |
START MARKETING DATE: | 2014-06-24 |
END MARKETING DATE: | 2018-02-28 |
PRODUCT ID: | 0378-7351_6279bfee-a9a4-4dd8-a226-c0b96a350158 |
PRODUCT NDC: | 0378-7351 |
APPLICATION NUMBER: | ANDA202395 |
Other ZIPRASIDONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: